000 01000 a2200289 4500
005 20250513043428.0
264 0 _c19950718
008 199507s 0 0 eng d
022 _a0028-3878
024 7 _a10.1212/wnl.45.6.1233
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChamberlain, M C
245 0 0 _aCNS lymphoma.
_h[electronic resource]
260 _bNeurology
_cJun 1995
300 _a1233 p.
_bdigital
500 _aPublication Type: Comment; Letter
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aCentral Nervous System Neoplasms
_xdrug therapy
650 0 4 _aCyclophosphamide
_xtherapeutic use
650 0 4 _aDoxorubicin
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aLymphoma
_xdrug therapy
650 0 4 _aPrednisone
_xtherapeutic use
650 0 4 _aVincristine
_xtherapeutic use
773 0 _tNeurology
_gvol. 45
_gno. 6
_gp. 1233
856 4 0 _uhttps://doi.org/10.1212/wnl.45.6.1233
_zAvailable from publisher's website
999 _c7783268
_d7783268